Time is slipping away from lawmakers who hope to resurrect a slate of changes to the pharmacy benefit manager (PBM) industry.
Three companies — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s OptumRX — control around 80% of ...
The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results